Compare IBRX & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IBRX | CVLT |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.2B | 7.0B |
| IPO Year | 2015 | 2006 |
| Metric | IBRX | CVLT |
|---|---|---|
| Price | $8.24 | $165.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 19 |
| Target Price | $14.25 | ★ $189.38 |
| AVG Volume (30 Days) | ★ 13.5M | 643.0K |
| Earning Date | 11-10-2026 | 10-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.71 | N/A |
| EPS | N/A | ★ 1.19 |
| Revenue | $113,288,000.00 | ★ $1,183,690,000.00 |
| Revenue This Year | $99.98 | $10.38 |
| Revenue Next Year | $108.29 | $7.06 |
| P/E Ratio | ★ N/A | $144.24 |
| Revenue Growth | ★ 668.31 | 18.89 |
| 52 Week Low | $1.95 | $71.75 |
| 52 Week High | $12.43 | $174.25 |
| Indicator | IBRX | CVLT |
|---|---|---|
| Relative Strength Index (RSI) | 43.83 | 56.95 |
| Support Level | $7.71 | $144.07 |
| Resistance Level | $8.51 | N/A |
| Average True Range (ATR) | 0.71 | 8.40 |
| MACD | -0.13 | 0.51 |
| Stochastic Oscillator | 18.18 | 67.90 |
ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.
CommVault Systems Inc provides cyber resiliency solutions designed to help the enterprise protect, secure, and recover its data, applications, and identity systems in a world of increasing cyber threats and attacks. Its offerings provide cyber resilience, including data protection, cyber recovery, data security, and governance, aiming to enable customers to continue business. The company delivers its solutions through Commvault Cloud, a cloud native platform that unifies data security, cyber recovery and identity resilience across on-premises, hybrid, multi-cloud, and software-as-a-service environments. It sells its offerings through subscription-based arrangements, including SaaS and term-based subscriptions, and also offers perpetual licenses, customer support, and professional services.